CelLBxHealth plc (AIM:CLBX)
London · Delayed Price · Currency is GBP · Price in GBX 0.9000
0.00 (0.00%)
Apr 17, 2026, 5:06 PM GMT
CelLBxHealth Market Cap
CelLBxHealth has a market cap or net worth of 10.23 million as of April 17, 2026. Its market cap has decreased by -66.62% in one year.
Market Cap
10.23M
Enterprise Value
8.62M
Revenue
2.62M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.90
Market Cap Chart
Since August 16, 2004, CelLBxHealth's market cap has decreased from 20.37M to 10.23M, a decrease of -49.79%. That is a compound annual growth rate of -3.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 10.23M | -18.18% |
| Dec 31, 2025 | 12.50M | -62.19% |
| Dec 31, 2024 | 33.06M | 8.02% |
| Dec 29, 2023 | 30.60M | -76.73% |
| Dec 30, 2022 | 131.54M | -52.97% |
| Dec 31, 2021 | 279.69M | 172.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 230.51B |
| GSK plc | 84.81B |
| Haleon | 31.43B |
| Smith & Nephew | 10.69B |
| Genflow Biosciences | 11.25M |
| RUA Life Sciences | 11.17M |
| Oxford BioDynamics | 9.23M |
| GENinCode | 8.85M |